Who We Are
Nixon Pharmaceutical Industries Ltd. (Nixon Pharmalab) is a start-up company that is based in the United States. We provide a range of effective solutions to optimize the delivery of generic prescription and OTC pharmaceutical products made in the USA. We provide the best possible range of international quality products at competitive prices through integration, research, innovation, technology and development. Our product will be approved for manufacturing either by the European Union and/or FDA.
At Nixon Pharmalab, we implement research and development initiatives that precisely address unmet medical needs in order to contribute and improve the quality and effectiveness of medical care in the future. Our strength lies in a highly capable manufacturing, R&D, and Quality Control-Quality Assurance system.
Nixon Pharmalab will be a partnership form of business organization. We invite investors and distributors to become a part of our Vision. We bring in the resources together, make the decisions, and manage the business sharing the profits and risks. Our vision is to provide medicines initially to US, and EU markets, especially in the solid dosage formulations like Capsules, tablets, cream, lotion, and ointment. Initially, our focus is "central nervous system" and “allergy” prescription and OTC products.